About
ABOUT IBG
MISSION-VISION
STRATEGIC OBJECTIVES
BOARD OF DIRECTORS
DIRECTOR
ORGANIZATION CHART
GENDER EQUALITY PLAN
ANNUAL REPORTS
COOPERATION MOVIE
Research
BASIC AND TRANSLATIONAL RESEARCH PROGRAM
TECHNOLOGICAL RESEARCH PROGRAM
INDUSTRIAL R&D PROGRAM
IBG-NEVCELL
DRUG ANALYSIS AND CONTROL LAB.
RARE AND UNDIAGNOSED DISEASES PLATFORM
ETHICS BOARDS
AWARDS
SCIENTIFIC PUBLICATIONS
Research Support
RESEARCH SUPPORT UNITS
Optical Imaging
Flow Cytometry and Cell Sorting
Electron Microscopy
Histopathology
General Device Operating
Vivaryum
PRICE LIST
TECHNOLOGY PLATFORMS
Gene Targeting and Transgenic Models Platform
IBG-BIP Bioinformatics Platform
IBG-Biobank
IBG-PHARMA
IBG-NEVCELL
Drug Analysis and Control Lab.
Rare and Undiagnosed Diseases Platform
RESERVATION SYSTEM
Training
CONFERENCES AND COURSES
SEMINARS
POSTDOCTORAL TRAINING
AFFILIATED GRADUATE PROGRAMMES
INTERNSHIP
Jobs
News
NEWS FROM IBG
IBG IN THE MEDIA
ANNOUNCEMENTS
Press
Contact
IBG DIRECTORY
CONTACT
Intranet
STS
Türkçe (tr)
English (en)
Home
Training
Seminars
Molecular Mechanisms Underlying Development of HCC in the Setting of Obesity and NAFLD
Molecular Mechanisms Underlying Development of HCC in the Setting of Obesity and NAFLD
Dec. 7, 2018
